Always private
DuckDuckGo never tracks your searches.
Learn More
You can hide this reminder in Search Settings
All regions
Argentina
Australia
Austria
Belgium (fr)
Belgium (nl)
Brazil
Bulgaria
Canada (en)
Canada (fr)
Catalonia
Chile
China
Colombia
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India (en)
Indonesia (en)
Ireland
Israel (en)
Italy
Japan
Korea
Latvia
Lithuania
Malaysia (en)
Mexico
Netherlands
New Zealand
Norway
Pakistan (en)
Peru
Philippines (en)
Poland
Portugal
Romania
Russia
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
Spain (ca)
Spain (es)
Sweden
Switzerland (de)
Switzerland (fr)
Taiwan
Thailand (en)
Turkey
Ukraine
United Kingdom
US (English)
US (Spanish)
Vietnam (en)
Safe search: moderate
Strict
Moderate
Off
Any time
Any time
Past day
Past week
Past month
Past year
  1. Only showing results from cordis.europa.eu

    Clear filter to show all search results

  2. cordis.europa.eu

    Oct 28, 2024PMSMatTrain. Grant agreement ID: 813263 Open in new window Project website DOI 10.3030 ... Longitudinal evaluation of the therapeutic effect of APRIL in the Cuprizone mouse model of Multiple Sclerosis. Author(s): Leonardo Ricciardi, Marion Decrop, Joëlle ... Molecular Research in Multiple Sclerosis Author(s): ...
  3. cordis.europa.eu

    The overall objectives of the research carried out by members of the PMSMatTrain consortium were to do the following: 1) develop improved lab-based and pre-clinical models of MS pathology; 2) use these models to test candidate drugs that inhibit inflammation and promote the repair of damaged nerves; 3) design a novel, minimally-invasive device ...
  4. cordis.europa.eu

    PMSMatTrain is focusing on gaining a comprehensive understanding of the progressive (late degenerative phase) of multiple sclerosis (PMS) from basics to translation, fully supported by 8 beneficiaries (6 research institutions, 2 SMEs). Recruited ESRs will receive compulsory...
  5. cordis.europa.eu

    Oct 14, 2024Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) are chronic diseases characterized by progressive or alternate impairment of neurological functions (motor, sensory, visual, cognitive). Patients have to manage alternated periods in hospital with care at home...
  6. cordis.europa.eu

    "Multiple Sclerosis (MS) is an inflammatory CNS disease that affects more than 2.5 million individuals worldwide. Damage to axonal connections determines the functional deficits of MS patients. How axons are damaged in MS is only incompletely understood. Using in vivo multiph...
  7. cordis.europa.eu

    Unos 2,5 millones de personas padecen esclerosis múltiple (EM) en todo el mundo. Se trata de una enfermedad inflamatoria crónica que afecta al sistema nervioso central (SNC). Unos investigadores de la Unión Europea estudiaron un agente molecular clave en el desarrollo y posible tratamiento de esta enfermedad.

    Can’t find what you’re looking for?

    Help us improve DuckDuckGo searches with your feedback

Custom date rangeX